Breast Cancer Clinical Trial
Official title:
Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle
NCT number | NCT03611543 |
Other study ID # | 16-03 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 20, 2016 |
Est. completion date | June 18, 2018 |
Verified date | May 2020 |
Source | Hologic, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this study is to evaluate patient comfort during compression with a standard flat mammographic paddle and an investigational curved paddle. This is a study that will be performed with x-ray imaging and will be used to determine if an overall reduction in pain can be appreciated in patients without loss in image quality as compared to the current standard mammogram. Another benefit of the curved paddle may be an increase of perceivable and measurable tissue capture.
Status | Completed |
Enrollment | 515 |
Est. completion date | June 18, 2018 |
Est. primary completion date | June 18, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 25 Years and older |
Eligibility |
Inclusion Criteria: - Subject is female of any race and ethnicity - Screening Subject is at least 40 years old, Diagnostic subjects are at least 25 years old - Subject will be referred for a screening or a diagnostic work-up with tomosynthesis as part of the exam Exclusion Criteria: - Subjects who are pregnant or who think they may be pregnant - Subjects lactating or presenting with discharge - Women too large for the detector - Subjects who cannot give informed consent |
Country | Name | City | State |
---|---|---|---|
United States | Solis Mammagroaphy | Addison | Texas |
United States | University Hospitals Cleveland Medical Center | Cleveland | Ohio |
United States | TOPS Comprehensive Breast Center | Houston | Texas |
United States | Elizabeth Wende Breast Clinic | Rochester | New York |
United States | Stamford Hospital | Stamford | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Hologic, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patient Comfort | Score of 1-10 on Universal Pain Assessment Tool | Day of Procedure (No Follow-up) | |
Secondary | Tissue Volume | Acceptable/Non-Acceptable determination on tissue coverage | Day of Procedure (No Follow-up) | |
Secondary | Image quality | Acceptable/Non-Acceptable determination on overall image quality | Day of Procedure (No Follow-up) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Recruiting |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |